INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 429m ago
HOUSE PTR28m ago
SEC 13F28m ago
ROBINHOOD CHAIN28m ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Mackin James P sold AORT

President & CEO · ARTIVION, INC. · Common Stock

Side
SELL
Value
$1.41M
Shares
30.9K
Price
$45.46
Executed
Dec 3, 2025
Disclosed
Dec 4, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 3 executedDec 4, 2025 disclosed

AORT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
19/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+10 / 25

    $1.4M reported value · 3.7% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · AORT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    35
    GM
    Green Andrew MSVP, Regulatory and Quality
    AORTARTIVION, INC.
    Open-market sale
    		SELL$287K
    11.5K sh
    		Sep 10, 2026Sep 11, 2026
    traded Sep 10, 2026
    		+1dSEC FORM 4

    Evidence

    20
    Gilbert Ray Cisneros, Jr.DSelf
    AORTARTIVION, INC.
    Purchase
    		BUY$1,001 – $15KAug 20, 2026Sep 10, 2026
    traded Aug 20, 2026
    		+21dHOUSE PTR

    Evidence

    39
    Gilbert Ray Cisneros, Jr.DSelf
    AORTARTIVION, INC.
    Purchase
    		BUY$1,001 – $15KJul 16, 2026Sep 4, 2026
    traded Jul 16, 2026
    		+50dHOUSE PTR

    Evidence

    29
    HF
    Holloway Jean FSVP, General Counsel
    AORTARTIVION, INC.
    Open-market sale
    		SELL$93K
    2,048 sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    5
    MP
    Mackin James PPresident & CEO
    AORTARTIVION, INC.
    Option exercise · 10b5-1 plan
    		M$916K
    30.9K sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    0
    MP
    Mackin James PPresident & CEO
    AORTARTIVION, INC.
    Option exercise · 10b5-1 plan
    		M—
    30.9K sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    29
    HF
    Holloway Jean FSVP, General Counsel
    AORTARTIVION, INC.
    Open-market sale
    		SELL$239K
    5,267 sh
    		Dec 3, 2025Dec 4, 2025
    traded Dec 3, 2025
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001628280-25-055466
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 3, 2025
    Published
    Dec 4, 2025
    Ingested by INSIDER
    Nov 5, 04:29 UTC
    Last re-read
    Nov 5, 04:29 UTC

    Extracted facts

    Filer
    Mackin James P
    Role
    President & CEO
    Transaction
    Open-market saleAs filed: “S”
    Asset
    ARTIVION, INC.
    Ticker
    AORT
    Shares
    30.9K
    Price per share
    $45.46
    Value
    $1,405,700
    Execution date (reported)
    Dec 3, 2025
    Owned after transaction
    801.0K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 30.9K
    • Price: $45.461

    = $1,405,700

    What this establishes

    Mackin James P filed this Form 4 reporting a open-market sale of AORT on Dec 3, 2025. It became public on Dec 4, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    President & CEO
    Mackin James Pcik:0001408470
    Issuer
    ARTIVION, INC.cik:0000784199

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.